ArticleACS nano2026
Chimeric Nanocurved Materials Reprogram Receptor Signaling to Induce Apoptosis via a Curvature-Sensing Protein.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The nanoscale curvature of cell membranes plays a regulatory role in cell activity and response. This paper reports chimeric nanocurved materials functionalized with EGF that are capable of reprogramming growth factor signaling via a curvature-sensing protein. We achieved this by integrating epidermal growth factor (EGF) onto the surface of various nanostructured materials, which were exposed to the apical surface of cell membranes. These materials selectively triggered apoptosis, in contrast to flat EGF-modified surfaces. Serial variation of the nanoscopic parameters of the EGF-functionalized nanomaterials confirmed that the synergistic combination of the nanocurved material-mediated stimulation and receptor activation is critical for apoptosis induction. RNA-seq revealed a shift toward a pro-apoptotic gene expression profile, characterized by the suppression of survival-related pathways and enhancement of apoptosis-associated signals. Furthermore, gene editing experiments demonstrated that the nanocurved materials recruit the curvature-sensing protein PACSIN2, which in turn modulates the signaling cascade to induce apoptosis. Our findings show that chimeric nanocurved EGF-functionalized materials reprogram EGFR signaling from pro-survival to pro-apoptotic outcomes via an endocytosis-independent pathway mediated by PACSIN2. This mechanism underscores the potential of engineered biointerfaces to control receptor-mediated cell fate and suggests opportunities for patch-based anticancer therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.